Assessment of the effectiveness of the CD3+ tool to detect counterfeit and substandard anti-malarials

BACKGROUND: The US FDA recently developed CD3+, a counterfeit detection tool that is based on sample illumination at specific wavelengths of light and visual comparison of suspect sample and packaging materials to an authentic sample. To test performance of the CD3+ in field conditions, a study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Batson, JaCinta S., Bempong, Daniel K., Lukulay, Patrick H., Ranieri, Nicola, Satzger, R. Duane, Verbois, Leigh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766612/
https://www.ncbi.nlm.nih.gov/pubmed/26917250
http://dx.doi.org/10.1186/s12936-016-1180-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766612/
https://www.ncbi.nlm.nih.gov/pubmed/26917250
http://dx.doi.org/10.1186/s12936-016-1180-2

Ejemplares similares